advertisement
Friedman DS 101
Showing records 1 to 25 | Display all abstracts from Friedman DS121060 Impact of Demographics on Regional Visual Field Loss and Deterioration in Glaucoma
Pang Y
Translational vision science & technology 2024; 13: 25
123357 Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data
Shi M
Translational vision science & technology 2024; 13: 11
122376 The Clinical Usefulness of a Glaucoma Polygenic Risk Score in 4 Population-Based European Ancestry Cohorts
de Vries VA
Ophthalmology 2024; 0:
119378 Treatment Patterns of Childhood Glaucoma in the United States: Analysis of IRIS Registry (Intelligent Research in Sight)
Fujita A
American Journal of Ophthalmology 2024; 271: 210-221
120172 Use of Diagnostic Codes for Primary Open-Angle Glaucoma Polygenic Risk Score Construction in Electronic Health Record-Linked Biobanks
Tran JH
American Journal of Ophthalmology 2024; 267: 204-212
119744 Prevalence of Glaucoma Among US Adults in 2022
Ehrlich JR
JAMA ophthalmology 2024; 142: 1046-1053
119570 Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Glaucoma in Patients With Type 2 Diabetes: A Target Trial Emulation
Eng K
American Journal of Ophthalmology 2024; 271: 286-298
121901 Glaucoma: now and beyond
Jayaram H
Lancet 2023; 402: 1788-1801
119744 Prevalence of Glaucoma Among US Adults in 2022
Burke-Conte Z
JAMA ophthalmology 2024; 142: 1046-1053
123357 Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data
Lokhande A
Translational vision science & technology 2024; 13: 11
120172 Use of Diagnostic Codes for Primary Open-Angle Glaucoma Polygenic Risk Score Construction in Electronic Health Record-Linked Biobanks
Kang J
American Journal of Ophthalmology 2024; 267: 204-212
122376 The Clinical Usefulness of a Glaucoma Polygenic Risk Score in 4 Population-Based European Ancestry Cohorts
Hanyuda A
Ophthalmology 2024; 0:
119570 Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Glaucoma in Patients With Type 2 Diabetes: A Target Trial Emulation
Zebardast N
American Journal of Ophthalmology 2024; 271: 286-298
121901 Glaucoma: now and beyond
Kolko M
Lancet 2023; 402: 1788-1801
121060 Impact of Demographics on Regional Visual Field Loss and Deterioration in Glaucoma
Tang M
Translational vision science & technology 2024; 13: 25
123357 Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data
Lokhande A
Translational vision science & technology 2024; 13: 11
119378 Treatment Patterns of Childhood Glaucoma in the United States: Analysis of IRIS Registry (Intelligent Research in Sight)
Vu DM
American Journal of Ophthalmology 2024; 271: 210-221
123357 Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data
Tian Y
Translational vision science & technology 2024; 13: 11
121060 Impact of Demographics on Regional Visual Field Loss and Deterioration in Glaucoma
Shi M
Translational vision science & technology 2024; 13: 25
119570 Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Glaucoma in Patients With Type 2 Diabetes: A Target Trial Emulation
Boland MV
American Journal of Ophthalmology 2024; 271: 286-298
119378 Treatment Patterns of Childhood Glaucoma in the United States: Analysis of IRIS Registry (Intelligent Research in Sight)
Aziz K
American Journal of Ophthalmology 2024; 271: 210-221
122376 The Clinical Usefulness of a Glaucoma Polygenic Risk Score in 4 Population-Based European Ancestry Cohorts
Vergroesen JE
Ophthalmology 2024; 0:
121901 Glaucoma: now and beyond
Friedman DS
Lancet 2023; 402: 1788-1801
120172 Use of Diagnostic Codes for Primary Open-Angle Glaucoma Polygenic Risk Score Construction in Electronic Health Record-Linked Biobanks
Han E
American Journal of Ophthalmology 2024; 267: 204-212
119744 Prevalence of Glaucoma Among US Adults in 2022
Wittenborn JS
JAMA ophthalmology 2024; 142: 1046-1053